List of insiders holdings for Denali Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | FMR LLC See Remark 1 |
2024-11-12 09:55:15 | 10,141,901 0 |
10,141,901 | Form 13G |
| 2 | NELSEN ROBERT Director |
2021-06-04 18:35:30 | 18,654 9,668,749 |
9,687,403 | Form 4 |
| 3 | BIOGEN INC. Biogen MA Inc. 10% Owner |
2024-11-07 16:48:26 | 7,155,243 0 |
7,155,243 | Form 13G |
| 4 | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
2024-02-13 16:27:05 | 5,750,882 0 |
5,750,882 | Form 13G |
| 5 | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner |
2024-02-13 16:27:05 | 5,750,882 0 |
5,750,882 | Form 13G |
| 6 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
2025-06-05 17:02:52 | 0 3,479,348 |
3,479,348 | Form 4 |
| 7 | Flagship Ventures Fund V L.P. AFEYAN NOUBAR Flagship Ventures Fund V General Partner LLC 10% Owner |
2021-02-16 17:08:00 | 2,730,263 0 |
2,730,263 | Form 13G |
| 8 | Watts Ryan J. President and CEO |
2025-01-08 20:24:43 | 253,071 2,202,604 |
2,455,675 | Form 4 |
| 9 | Tessier-Lavigne Marc Director |
2025-06-05 16:23:08 | 1,904,687 236,869 |
2,141,556 | Form 4 |
| 10 | FIL Ltd See Remark 1 |
2017-12-14 15:20:57 | 1,914,833 1,379 |
1,916,212 | Form 4 |
| 11 | Krognes Steve E. Director |
2025-06-05 16:29:16 | 49,905 781,797 |
831,702 | Form 4 |
| 12 | Schuth Alexander O. COFO and Secretary |
2025-01-08 20:25:44 | 244,308 523,749 |
768,057 | Form 4 |
| 13 | Ho Carole Chief Medical Officer |
2025-01-08 20:26:37 | 175,673 208,219 |
383,892 | Form 4 |
| 14 | FLATLEY JAY T Director |
2025-06-05 16:33:18 | 34,331 336,313 |
370,644 | Form 4 |
| 15 | SATO VICKI L Director |
2025-01-03 16:13:51 | 107,976 0 |
107,976 | Form 4 |
| 16 | Schenkein David P Director |
2025-06-05 16:26:51 | 33,368 57,464 |
90,832 | Form 4 |
| 17 | Klein Peter S Director |
2025-06-05 16:31:24 | 45,644 0 |
45,644 | Form 4 |
| 18 | Cook Jennifer E. Director |
2025-06-05 16:34:17 | 44,186 0 |
44,186 | Form 4 |
| 19 | Thornberry Nancy Director |
2025-06-05 16:25:53 | 42,828 0 |
42,828 | Form 4 |
| 20 | Cole Douglas G. Director |
2023-06-05 18:01:14 | 39,213 0 |
39,213 | Form 4 |
| 21 | Harris Erik Director |
2024-06-04 18:27:58 | 34,953 0 |
34,953 | Form 4 |
| 22 | ARCH Venture Fund VIII L.P. ARCH Venture Partners VIII L.P. ARCH Venture Partners VIII LLC BYBEE CLINTON CRANDELL KEITH 10% Owner |
2022-02-08 15:04:10 | 0 0 |
0 | Form 13G |